InvestorsHub Logo
Followers 64
Posts 6479
Boards Moderated 0
Alias Born 03/17/2017

Re: abew4me post# 243165

Wednesday, 03/25/2020 5:43:41 PM

Wednesday, March 25, 2020 5:43:41 PM

Post# of 468503

Well, when Biogen released their results, the market boosted their share price an extra $9 BILLION...and that's with very questionable results.

If AVXL has excellent results, they should get the same kind of pop. And don't forget, AVXL's drugs are being tested for a whole range of CNS diseases...so I expect the valuation to be MUCH more than $9 Billion.

As I said before, investing in small biotech companies (like AVXL) is one of the best ways for a small investor to become extremely wealthy.

Hold tight.




Look, when Biogen announced their questionable results, they added one little detail you seem to forget which boosted their SP. They told the market they will apply for approval....

The PDD data results are P2 results. Its up to the company if they think they will have a snowball chance to apply for PA. There are 3 options if great trial data is announced:
A. wonderful data blabla we will initiate PA
B. wonderful data we are encouraged and excited blabla we are looking with confidence forward to P3
C. wonderful data we are encouraged and excited blabla nothing about PA
Only when option A is announced SP will soar extensively, is my expectation. When option B or C is announced then I see a temporary SP rise...

Biotechs are almost in all cases only rewarded if there is a realistic outlook for great revenue in the near future.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News